IL2 and edema: Due to the short blood half-life and poor pharmacokinetics of IL-2 and the imperative to achieve a potent immunomodulatory effect, a high dose of IL-2 is often needed, inevitably causing severe systemic toxicity, including vascular leak syndrome, pulmonary edema, hypotension, acute renal insufficiency, and, rarely, myocarditis39.